Neurotoxigenic Clostridia

Pathogenesis of Bacterial Infections in Animals: Fourth Edition

Volumn , Issue , 2010, Pages 189-202

  Bohnel H ^a   Gessler, F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Clostridium botulinum producing biofilms; Flaccid tail, drooping ears indicative of acute toxicosis; Human tetanus severe polysystemic disease; Neurotoxigenic clostridia; Neurotoxigenic clostridia gram positive, anaerobic, rod shaped, spore formers; Probiotics impacting intestinal microbiota; Tetanolysin cholesterol dependent cytolysin

Indexed keywords

EID: 84872208905     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470958209.ch11     Document Type: Chapter

References (108)

1. Akbulut, D., K. A. Grant, and J. McLauchlin. 2005. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. J. Clin. Microbiol. 43:4342-4348.
2. Aktories, K., M. Bärmann, I. Ohishi, S. Tsuyama, K. H. Jakobs, and E. Habermann. 1986. Botulinum C2 toxin ADP-ribosylates actin. Nature 322:390-392.
3. Aktories, K., U. Weller, and G. S. Chhatwal. 1987. Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. FEBS Lett. 212:109-113.
4. Aktories, K., M. Willie, and I. Just. 1992. Clostridial actin-ADP-ribosylating toxins. Curr. Top. Microbiol. Immunol. 175:97-113.
5. Akulinicheva, K. V. 1989. C1. Tetani vitality under aerobic conditions: hypothesis and facts. In The eighth international conference on tetanus. Leningrad. G. Nisticò, P. Mastroeni, M. Pitzurra (eds.). Rome: Pythagoras, pp. 20-25.
6. Arnon, S. S., T. Midura, S. Clay, R. Wood, and J. Chin. 1977. Infant botulism: epidemiological, clinical, and laboratory aspects. J. Am. Med. Assoc. 237:1946-1951.
7. Azuma, R., and T. Itoh. 1987. Botulism in water fowl and distribution of C. botulinum type C in Japan. In Avian botulism. M. W. Eklund and V. R. Dowell (eds.). An international perspective. Springfield, IL: C.C. Thomas, pp. 167-187.
8. Bizzini, B. 1979. Tetanus toxin. Microbiol. Rev. 43:224-240.
9. Böhnel, H. 2002. Household biowaste containers (bio-bins)-potential incubators for Clostridium botulinum and botulinum neurotoxins. Water Air SoilPollut. 140:335-341.
10. Böhnel, H. 2005. Akuter Botulismus bei Steinb ö cken in einem Wildgehege nach Silagefütterung-Ein Hinweis. Zool. Gart. 75:116-121.
11. Böhnel, H., and F. Gessler. 2003. Botulismusdiagnose seit 1995. Ein Erfahrungsbericht. Berl. Münch. Tierärztl. Wochenschr. 116:269-273.
12. Böhnel, H., and F. Gessler. 2005. Botulinum toxins-cause of botulism and systemic diseases? Vet. Res. Commun. 29:313-345.
13. Böhnel, H., B. Schwagerick, and F. Gessler. 2001. Visceral botulism-a new form of bovine Clostridium botulinum toxication. J. Vet. Med. Assoc. 48:373-383.
14. Böhnel, H., B. Neufeld, and F. Gessler. 2004. Botulinum neurotoxin type B in milk from a cow affected by visceral botulism. Vet. J. 169:124-125.
15. Böhnel. H., U. Wernery, and F. Gessler. 2003. Two cases of equine grass sickness with evidence for soil-borne origin involving botulinum neurotoxin. J. Vet. Med. B Infect. Dis. Vet. Public Health 50:178-182.
16. Boyer, A., C. Girault, F. Bauer, J. Korach, J. Salomon, E. Moirot, et al. 2001. Two cases of foodborne botulism type E and review of epidemiology in France. Eur. J. Clin. Microbiol. Infect. Dis. 20:192-195.
17. Bradshaw, M., S. S. Dineen, N. D. Maks, and E. A. Johnson. 2004. Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916. Anaerobe 10:321-333.
18. Brandis, H., W. Köhler, H. J. Eggers, and G. Pulverer. 1994. Lehrbuch der Medizinischen Mikrobiologie, 7th ed. Stuttgart: Fischer.
19. Brüggemann, H., and G. Gottschalk. 2004. Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani. Anaerobe 10:53-68.
20. Cai, S., B. R. Singh, and S. Sharma. 2007. Botulism diagnostics: from clinical symptoms to in vitro assays. Crit. Rev. Microbiol. 33:109-125.
21. Cann, D. C., and L. Y. Taylor. 1982. An outbreak of botulism in rainbow trout, Salmo gairdneri Richardson, farmed in Britain. J. Fish Dis. 5:393-399.
22. Carle, A., and G. Rattone. 1884. Studio sperimentale sull'eziologia del tetano. G. Accad. Med. 32:174.
23. Chai, Q., J. W. Arndt, M. Dong, W. H. Tepp, E. A. Johnson, E. R. Chapman, et al. 2006. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 444:1096-1100.
24. Chen, C., M. R. Baldwin, and J. T. Barbieri. 2008. Molecular basis for tetanus toxin coreceptor interactions. Biochemistry 47:7179-7186.
25. Chen, Y., H. Korkeala, J. Aarnikunnas, and M. Lindstrom. 2007. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J. Bacteriol. 189:8643-8650.
26. Clark, W. E. 1987. Avian botulism. In Avian botulism. An international perspective. M. W. Eklund and V. R. Dowell (eds.). Springfield, IL: C.C. Thomas, pp. 89-105.
27. Constable, P. D. 2005. Diseases of the abomasum. In The Merck veterinary manual, 9th ed. C. M. Kahn and S. Line (eds.). Whitehouse Station, NJ: Merck & Co., pp. 193-196.
28. Cook, T. M., R. T. Protheroe, and J. M. Handel. 2001. Tetanus: a review of the literature. Brit. J. Anaesth. 87:477-487.
29. Dahlenborg, M., E. Borch, and P. Radström. 2001. Development of a combined selection and enrichment PCR procedure for Clostridium botulinum types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs. Appl. Environ. Microbiol. 67:4781-4788.
30. Dahlenborg, M., E. Borch, and P. Radström. 2003. Prevalence of Clostridium botulinum types B, E, and F in faecal samples from Swedish cattle. Int. J. Food. Microbiol. 10:105-110.
31. Dong, M., F. Yeh, W. H. Tepp, C. Dean, E. A. Johnson, R. Janz, et al. 2006. SV2 is the protein receptor for Botulinum neuro toxin A. Science 312:592-596.
32. Durant, A. J. 1928. Limberneck (botulism) in fowls. Vet. Med. 23:225-227.
33. 125I-tetanus toxin in early local tetanus. Naunyn Schmiedeberg Arch. Pharmacol. 290:357-373.
34. Ermert, L., H. R. Duncker, H. Brückner, F. Grimminger, T. Hansen, R. Rössig, et al. 1997. Ultrastructural changes of lung capillary endothelium in response to botulinum C2 toxin. J. Appl. Physiol. 82:382-388.
35. Finn, C. W., R. P. Silver, W. H. Habig, M. C. Hardegree, G. Zon, and C. F. Garon. 1984. The structural gene for tetanus neurotoxin is on a plasmid. Science 224:881-884.
36. Frey, J., S. Eberle, C. Stahl, C. Mazuet, M. Popoff, E. Schatzmann, et al. 2007. Alternative vaccination against equine botulism (BoNT/C). Equine Vet. J. 39:516-520.
37. Fu, S.-W., and C. Wang. 2008. An overview of type E botulism in China. Biomed. Environ. Sci. 21:353-356.
38. Fujihashi, K., H. F. Staats, S. Kozaki, and D. W. Pascual. 2007. Mucosal vaccine development for botulinum intoxication. Expert Rev. Vaccines 6:35-45.
39. Gerber, V., R. Straub, and J. Frey. 2006. Equine botulism and acute pasture myodystrophy: new soil-borne emerging diseases in Switzerland? Schweiz. Arch. Tierheilkd. 148:553-559.
40. Gill, D. M. 1982. Bacterial toxins. A table of lethal amounts. Microbiol. Rev. 46:86-94.
41. Giménez, D. F., and A. S. Ciccarelli. 1970. Another type of Clostridium botulinum. Zentralbl Bakteriol Orig. 215:212-220.
42. Giménez, D. F., and J. A. Giménez. 1993. Serological subtypes of botulinal neurotoxins. In Botulism and tetanus neurotoxins: neurotransmission and biomedical aspects. B. R. DasGupta (ed.). New York: Plenum Press, pp. 625-626.
43. Gottlieb, S. L., K. Kretsinger, N. Tarkhashvili, N. Chakvetadze, M. Chokheli, M. Chubinidze, et al. 2007. Long-term outcomes of 217 botulism cases in the Republic of Georgia. Clin. Infect. Dis. 45:174-180.
44. Green, A. L., J. E. Lombard, L. P. Garber, B. A. Wagner, and G. W. Hill. 2008. Factors associated with occurrence and recovery of nonambulatory dairy cows in the United States. J. Dairy Sci. 91:2275-2283.
45. Hill, K. K., T. J. Smith, C. H. Helma, L. O. Ticknor, B. T. Foley, R. T. Svensson, et al. 2006. Genetic diversity among botulinum neurotoxin producing strains. J. Bacteriol. 189:818-832.
46. Hunter, L. C., and I. R. Poxton. 2001. Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)? Equine Vet. J. 33:547-553.
47. Hunter, L. C., J. K. Miller, and I. R. Poxton. 1999. The association of Clostridium botulinum type C with equine grass sickness in horses. Equine Vet. J. 31:492-499.
48. Ishii, T., K. Nagai, N. Nagatmatsu, M. Niiro, N. Sakurai, E. Sakusabe, et al. 1989. Aetiology of milk allergy with homologous and heterolgous tetanus antritoxin. I. Transintestinal transmission of tetanus antitoxin in new-born calves. In the eighth international conference on tetanus. G. Nisticó, B. Bizzini, B. Bytchenko, and R. Triau (eds.). Rome: Pythagora, pp. 434-438.
49. Jansen, B. C., P. C. Knoetze, and F. Visser. 1976. The antibody response of cattle to Clostridium botulinum types C and D toxoids. Onderstepoort J. Vet. Res. 43:165-173.
50. Jin, R. S., A. Rummel, T. Binz, and A. T. Brunger. 2006. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444:1092-1095.
51. Johnson, E. A. 2005. Clostridial neurotoxins. In Handbook on clostridia. P. Dürre (ed.). Boca Raton: CRC Press, pp. 491-525.
52. Johnson, E. A. 2006. Clostridium botulinum and Clostridium tetani. In Topley & Wilson's microbiology and microbial infections, vol. 2, 10th ed. S. P. Boriello, P. R. Murray, and G. Funke (eds.). London: Hodder Arnold, pp. 1035-1088.
53. Johnson, E. A., and M. Bradshaw. 2001. Clostridium botulinum: a metabolic and cellular perspective. Toxicon 39:1703-1722.
54. Kelch, W. J., L. A. Kerr, J. K. Pringle, B. W. Rohrbach, and R. H. Whitlock. 2000. Fatal Clostridium botulinum toxicosis in eleven Holstein cattle fed round bale barley haylage. J. Vet. Invest. 12:453-455.
55. Kerner, J. 1820. Neue Beobachtungenüber die in Würtemberg so häufig vorfallenden tödtlichen Vergiftungen durch den Genuß geräucherter Würste. Osiander, Tübingen.
56. Kreft, J. 2004. Conflicts of interest in biofilm. Biofilms 1:265-276.
57. Lacy, D. B., and R. C. Stevens. 1999. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291:1091-1104.
58. Lewis, G. E., S. Kulinski, E. H. Fallon, J. P. Klyza, and J. T. Bryans. 1981. Evaluation of a Clostridium botulinum toxoid, type B, for the prevention of shaker foal syndrome. P. Annu. Conv. Am. Equin. 27:233-237.
59. Lindström, M., and H. Korkeala. 2006. Laboratory diagnostics of botulism. Clin. Microbiol. Rev. 24:298-314.
60. Lindström, M., M. Nevas, J. Kurki, R. Sauna-Aho, A. Latvala-Kiesila, I. Polonen, et al. 2004. Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland. J. Clin. Microbiol. 42:4718-4725.
61. Marshall, K. M., M. Bradshaw, S. Pellet, and E. A. Johnson. 2007. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem. Biophys. Res. Commun. 361:49-54.
62. Marvaud, J. C., U. Eisel, T. Binz, H. Niemann, and M. R. Popoff. 1998. tetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect. Immun. 66:56985702.
63. Matsuda, M., N. Sugimoto, A. Haque, Y. Horiguchi. 1993. Target(s) of lethal action of Botulinolysin and Tetanolysin, thiol-activated cytotoxins of Clostridium botulinum and Clostridium tetani. Med. Microbiol. Immun. 182:201.
64. McCroskey, L. M., and C. L. Hatheway. 1984, Atypical strains of Clostridium botulinum isolated from specimens in infant botulism cases. Abstr. Annu. Meet. Am. Soc. Microbiol. 84 : C159-C263.
65. McCroskey, L. M., C. L. Hatheway, B. A. Woodruff, J. A. Greenberg, and P. Jurgenson. 1991. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J. Clin. Microbiol. 29:2618-2620.
66. McGorum, B. C., K. Kyles, D. Prince, C. N. Hahn, and I. G. Mayhew. 2003. Clinico-pathological features consistent with both botulism and grass sickness in a foal. Vet. Rec. 152:334-336.
67. Meyer, K. F. 1928. Botulismus. In Handbuch der pathogenen Mikroorganismen. 3. Aufl. Bd. IV, 2. W. Kolle and P. Kraus (eds.). Jena : Fischer und Urban&Schwarzenberg, pp. 1269-1364.
68. Millan, J., and A. J. Ridley. 2005. Rho GTPases and leucocyte-induced endothelial remodelling. Biochem. J. 385:329-337.
69. Miyazaki, S., and G. Sakaguchi. 1978. Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin. Jpn. J. Med. Sci. Biol. 31:1-15.
70. Moeller, R. B., B. Puschner, R. L. Walker, T. Rocke, F. D. Galey, J. S. Cullor, et al. 2003. Determination oft he median toxic dose of type C botulinum toxin in lactating dairy cows. J. Vet. Diagn. Invest. 15:523-526.
71. Montecucco, C., O. Rossetto, and G. Schiavo. 2004. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 12:442-446.
72. Montecucco, C., and G. Schiavo. 1995. Structure and function of tetanus and botulinum neurotoxins. Q. Rev. Biophys. 28:423-472.
73. Moriishi, K., M. Koura, N. Abe, N. Fujii, Y. Fujinaga, K. Inoue, et al. 1996. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim. Biophys. Acta. 1307:123-126.
74. Muylle, E., W. Oyaert, L. Ooms, and H. Decraemere. 1975. Treatment of tetanus in the horse by injections of tetanus antitoxins into the subarachnoidal space. J. Am. Vet. Med. Assoc. 167:47-48.
75. Nicolaier, A. 1884. über infectiösen Tetanus. Dtsch. Med. Wochenschr. 10:842-844.
76. Nusrat, A., M. Giry, J. R. Turner, S. P. Colgan, C. A. Parkos, D. Carnes, et al. 1995. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc. Natl. Acad. Sci. U S A 92:10629-10633.
77. Oguma, K., K. Inoue, Y. Fujinaga, K. Yokota, T. Watanabe, T. Ohyama, et al. 1999. Structure and function of Clostridium botulinum progenitor toxin. J. Toxicol. Toxin Rev. 18:17-34.
78. Oguma, K., B. Syuto, H. Iida, and S. Kubo. 1980. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect. Immun. 30:656-660.
79. Ohishi, I. 1983. Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components. Infect. Immun. 40:691-695.
80. Ohishi, I., M. Iwasaki, and G. Sakaguchi. 1980. Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimiöar protein components. Infect. Immun. 31:890-895.
81. Pamukcu, A. M. 1954. Hemorrhagic encephalomyelitis due to botulism in cattle in Turkey. Zentralbl. Veterinarmed. 1:707-722.
82. Popoff, M. R. 1989. Revue sur l'épidemiologie du botulism bovin en France et l'analyse de sa relation avec les élevages de volailles. Rev. Sci. Techn. 8:129-145.
83. Radostits, O. M., C. C. Gay, D. C. Blood, and K. W. Hinchcliff. 2000. Botulism. In Veterinary medicine: a textbook of the diseases of cattle, sheep, goats, pigs and horses, 9th ed. Radostits, O. M., C. C. Gay, D. C. Blood, and K. W. Hinchcliff (eds.). London: W.B. Saunders, 757-776.
84. Raffestin, S., B. Dupuy, J. C. Marvaud, and M. R. Popoff. 2005. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani. Mol. Microbiol. 55:235-249.
85. Rocke, T. E., and M. Friend. 2008. Avian botulism. In Field manual of wildlife diseases. General field procedures and diseases of birds. M. Friend, J. C. Franson, and E. A. Ciganovich (eds.). Wisconsin: USGS, pp. 271-281.
86. Saeed, E. M. A. 2005. Studies on isolation and identification of Clostridium botulinum investigating field samples specially from equine grass sickness cases. PhD thesis, Göttingen University.
87. Sakaguchi, G., S. Kozaki, and I. Ohishi. 1984. Structure and function of botulism toxins. In Bacterial protein toxins. J. E. Alouf, F. Fehrenbach, J. Freer, and J. Jeljaszewicz (eds.). London: Academic Press, pp. 435-443.
88. Sanada, I. 1964. A taxonomical relationship between Cl. tetani and Cl. cochlearium. Med. Biol. 68:123-127.
89. Schiavo, G., F. Benfenati, B. Poulain, O. Rossetto, P. Polverino de Laureto, B. R. DasGupta, et al. 1992. Tetanus and botulinum B neurotoxins block transmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832-835.
90. Schwab, M. E., K. Suda, and H. Thoenen. 1979. Selective retrograde trans-synaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport. J. Cell Biol. 82:798-810.
91. Schwagerick, B., and H. Böhnel. 2001. Eine chronische Erkrankung bei Milchkühen mit Nachweis von Botulinumtoxin-eine Fallstudie. Prakt. Tierarzt 82:516-524.
92. Simpson, L. L. 2004. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44:167-193.
93. Smith, L. D. 1975. The pathogenic anaerobic bacteria, 2nd ed. Springfield, IL: C.C. Thomas.
94. Smith, T. J., K. K. Hill, B. T. Foley, J. C. Detter, A. C. Munk, D. C. Bruce, et al. 2007. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and B1 clusters are located within plasmids. PLoS ONE 2:e1271.
95. Smith, L. D., and G. Hobbs. 1974. Genus III. Clostridium Prazmowski 1880. In Bergey's manual of determinative bacteriology, 8th ed., R. E. Buchanan and N. E. Gibbons (eds.). Baltimore: Williams and Wilkins, pp. 551-572.
96. Smith, T. J., J. Lou, I. N. Geren, C. M. Forsyth, R. Tsai, S. L. LaPorte, et al. 2005. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 73:5450-5457.
97. Smith, L. A., and J. M. Rusnak. 2007. Botulinum neurotoxin vaccines: past, present, and future. Crit. Rev. Immunol. 27:303-318.
98. Smith, L. D., and H. Sugiyama. 1988. Botulism. The organism, its toxins, the disease, 2nd ed. Springfield, IL: C.C. Thomas.
99. Stewart, P. S. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 292:107-113.
100. Takano, K., K. Kanada, F. Kirchern, P. Terhaar, B. Tiebert, and M. Mizote. 1981. Blocking effect of tetanus toxin on the excitatory synapse on the motoneurone of the spinal cord. In The sixth international conference on tetanus. Lyon : Fondation Mérieux, pp. 83-89.
101. Theiler, A., and E. M. Robinson. 1927. Der Botulismus der Haustiere. Z. Hyg. Infektionskr. 31:165-220.
102. Turner, L., and P. Simpson. 2006. Botulism in dairy cattle. Why annual vaccination may be crucial. DPI & F note. http://www2.dpi.qld.gov.au/dairy/18520.html.
103. Tweten, R. K. 1997. The thiol-activated clostridial toxins. In The clostridia: molecular biology and pathogenesis. J. I. Rood, B. A. McClane, J. G. Songer, and R. W. Titball. San Diego : Academic Press, pp. 211-221.
104. Umesaki, Y., H. Setoyama, S. Matsumoto, A. Imaoka, and K. Itoh. 1999. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect. Immun. 67:3504-3511.
105. Van Ermengem, E. 1897. Ueber einen neuen anaëroben Bacilus und seine Beziehungen zum Botulismus. Zeitschrift für Hygiene und Infektionskrankheiten (Leipzig) 26:1-56.
106. Vogelsgesang, M., A. Pautsch, and K. Aktories. 2007. C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn Schmiedebergs Arch. Pharmacol. 374:347-360.
107. Wilson, W. D., J. E. Mihalyi, S. Hussey, and D. P. Lunn. 2001. Passive transfer of maternal immuno-globin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet. J. 33:644-650.
108. Yamakawa, K., S. Kamiya, K. Yoshimura, and S. Nakamura. 1992. Clostridium botulinum type C in healthy swine in Japan. Microbiol. Immunol. 36:29-34.